Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15
Michelle Ng,
Lonneke Verboon,
Hasan Issa,
Raj Bhayadia,
Marit Willemijn Vermunt,
Robert Winkler,
Leah Schüler,
Oriol Alejo,
Konstantin Schuschel,
Eniko Regenyi,
Dorit Borchert,
Michael Heuser,
Dirk Reinhardt,
Marie-Laure Yaspo,
Dirk Heckl,
Jan-Henning Klusmann
Affiliations
Michelle Ng
Department of Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
Lonneke Verboon
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Hasan Issa
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Raj Bhayadia
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Marit Willemijn Vermunt
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Robert Winkler
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Leah Schüler
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Oriol Alejo
Department of Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
Konstantin Schuschel
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany
Eniko Regenyi
Department of Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
Dorit Borchert
Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany
Michael Heuser
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany
Dirk Reinhardt
Clinic for Pediatrics III, University Hospital Essen, 45147 Essen, Germany
Marie-Laure Yaspo
Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
Dirk Heckl
Institute for Experimental Pediatric Hematology and Oncology, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Corresponding author
Jan-Henning Klusmann
Department of Pediatrics, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60323 Frankfurt (Main), Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany; Corresponding author
Summary: The noncoding genome presents a largely untapped source of new biological insights, including thousands of long noncoding RNA (lncRNA) loci. While lncRNA dysregulation has been reported in myeloid malignancies, their functional relevance remains to be systematically interrogated. We performed CRISPRi screens of lncRNA signatures from normal and malignant hematopoietic cells and identified MYNRL15 as a myeloid leukemia dependency. Functional dissection suggests an RNA-independent mechanism mediated by two regulatory elements embedded in the locus. Genetic perturbation of these elements triggered a long-range chromatin interaction and downregulation of leukemia dependency genes near the gained interaction sites, as well as overall suppression of cancer dependency pathways. Thus, this study describes a new noncoding myeloid leukemia vulnerability and mechanistic concept for myeloid leukemia. Importantly, MYNRL15 perturbation caused strong and selective impairment of leukemia cells of various genetic backgrounds over normal hematopoietic stem and progenitor cells in vitro, and depletion of patient-derived xenografts in vivo.